Citations (124)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Kamal Razavi-Azarkhiavi, Milad Iranshahy, Amirhossein Sahebkar, Kobra Shirani & Gholamreza Karimi. (2016) The Protective Role of Phenolic Compounds Against Doxorubicin-induced Cardiotoxicity: A Comprehensive Review. Nutrition and Cancer 68:6, pages 892-917.
Read now
Read now
Ferda Alpaslan Pınarlı, Nilüfer N. Turan, Faruk Güçlü Pınarlı, Arzu Okur, Devrim Sönmez, Tulga Ulus, Aynur Oğuz, Ceyda Karadeniz & Tuncay Delibaşı. (2013) Resveratrol and Adipose-derived Mesenchymal Stem Cells Are Effective in the Prevention and Treatment of Doxorubicin Cardiotoxicity in Rats. Pediatric Hematology and Oncology 30:3, pages 226-238.
Read now
Read now
Kazim Sahin, Nurhan Sahin & Omer Kucuk. (2010) Lycopene and Chemotherapy Toxicity. Nutrition and Cancer 62:7, pages 988-995.
Read now
Read now
Ayliz Velioğlu-Öğünç, Özer Şehirli, Hale Z. Toklu, Hazan Özyurt, Alpaslan Mayadağli, Emel Ekşioğlu-Demiralp, Can Erzik, Şule Çetinel, Berrak Ç. Yeğen & Göksel Şener. (2009) Resveratrol protects against irradiation-induced hepatic and ileal damage via its anti-oxidative activity. Free Radical Research 43:11, pages 1060-1071.
Read now
Read now
Ali Solmaz, Göksel Şener, Şule Çetinel, Meral Yüksel, Cumhur Yeğen & Berrak Ç. Yeğen. (2009) Protective and therapeutic effects of resveratrol on acetic acid-induced gastric ulcer. Free Radical Research 43:6, pages 594-603.
Read now
Read now
Articles from other publishers (119)
Ahmet Özer Şehirli, Umut Aksoy, Abdullah Sibai, Kaan Orhan & Serkan Sayıner. (2023) Effects of N‐acetyl‐L‐cysteine against apical periodontitis in rats with adriamycin‐induced cardiomyopathy and nephropathy. International Endodontic Journal.
Crossref
Crossref
Yunshu Liao & Qinghua Meng. (2023) Protection against cancer therapy-induced cardiovascular injury by planed-derived polyphenols and nanomaterials. Environmental Research 238, pages 116896.
Crossref
Crossref
Natalia Bailon-Moscoso, José Coronel-Hidalgo, Rodrigo Duarte-Casar, Luis Miguel Guamán-Ortiz, Jorge G. Figueroa & Juan Carlos Romero-Benavides. (2023) Exploring the Antioxidant Potential of Tragia volubilis L.: Mitigating Chemotherapeutic Effects of Doxorubicin on Tumor Cells. Antioxidants 12:11, pages 2003.
Crossref
Crossref
He Xu, Hao You, Jixing Gong, Ying Zhang, Jianyong Du, Xinyu Wang, Shanshan Gu, Nan Cao & Jia Wang. (2023) Discovery of Zidovudine as a cardiomyocyte protectant for doxorubicin-induced toxicity through high-throughput phenotypic drug screening. Fundamental Research.
Crossref
Crossref
Bin Leng, Lin Deng, Jianxin Tan, Wei-Thye Lee, Cheng-Rui Cao, Zi-Ping Wang, De-Jian Huang, Xiaowei Nie & Jin-Song Bian. (2023) Targeting the Na+/K+ ATPase DR-region with DR-Ab improves doxorubicin-induced cardiotoxicity. Free Radical Biology and Medicine 204, pages 38-53.
Crossref
Crossref
Hamidreza Dorostkar, Bibi Fatemeh Haghiralsadat, Mahdie Hemati, Fatemeh Safari, Azam Hassanpour, Seyed Morteza Naghib, Mohammad Hossein Roozbahani, M. R. Mozafari & Ali Moradi. (2023) Reduction of Doxorubicin-Induced Cardiotoxicity by Co-Administration of Smart Liposomal Doxorubicin and Free Quercetin: In Vitro and In Vivo Studies. Pharmaceutics 15:7, pages 1920.
Crossref
Crossref
Sepideh Mirzaei, Mohammad Hossein Gholami, Amirhossein Zabolian, Hossein Saleki, Morteza Bagherian, Seyed Mohammadreza Torabi, Seyed Omid Sharifzadeh, Kiavash Hushmandi, Kaila R. Fives, Haroon Khan, Milad Ashrafizadeh, Ali Zarrabi & Anupam Bishayee. (2023) Resveratrol Augments Doxorubicin and Cisplatin Chemotherapy: A Novel
Therapeutic Strategy. Current Molecular Pharmacology 16:3, pages 280-306.
Crossref
Crossref
Mandeep Singh, Mustafa M. Kadhim, Abduladheem Turki Jalil, Shamam Kareem Oudah, Zafar Aminov, Fahad Alsaikhan, Zanko Hassan Jawhar, Andrés Alexis Ramírez-Coronel & Bagher Farhood. (2023) A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity. Cancer Cell International 23:1.
Crossref
Crossref
Armineh Rezagholi Lalani, Fatemeh Fakhari, Shakila Radgoudarzi, Nima Rastegar‐Pouyani, Kave Moloudi, Ehsan Khodamoradi, Shahram Taeb & Masoud Najafi. (2023) Immunoregulation by resveratrol; implications for normal tissue protection and tumour suppression. Clinical and Experimental Pharmacology and Physiology 50:5, pages 353-368.
Crossref
Crossref
Alexi Vasbinder, Richard K. Cheng, Susan R. Heckbert, Hilaire Thompson, Oleg Zaslavksy, Rowan T. Chlebowski, Aladdin H. Shadyab, Lisa Johnson, Jean Wactawski-Wende, Gretchen Wells, Rachel Yung, Lisa Warsinger Martin, Electra D. Paskett & Kerryn Reding. (2022) Chronic Oxidative Stress as a Marker of Long-term Radiation-Induced Cardiovascular Outcomes in Breast Cancer. Journal of Cardiovascular Translational Research 16:2, pages 403-413.
Crossref
Crossref
Peyman Amini, Reza Moazamiyanfar, Mohammad Sedigh Dakkali, Ali Khani, Emad Jafarzadeh, Kave Mouludi, Ehsan Khodamoradi, Ramin Johari, Shahram Taeb & Masoud Najafi. (2023) Resveratrol in Cancer Therapy: From Stimulation of Genomic Stability to
Adjuvant Cancer Therapy: A Comprehensive Review. Current Topics in Medicinal Chemistry 23:8, pages 629-648.
Crossref
Crossref
Mingyue Tan, Yunfei Yin, Xiao Ma, Jun Zhang, Wanqian Pan, Minghao Tan, Yongjian Zhao, Tianke Yang, Tingbo Jiang & Hongxia Li. (2023) Glutathione system enhancement for cardiac protection: pharmacological options against oxidative stress and ferroptosis. Cell Death & Disease 14:2.
Crossref
Crossref
Rana Shafabakhsh, Russel J. Reiter, Michael Aschner, Hamed Mirzaei & Zatollah Asemi. (2023) Resveratrol and Cervical Cancer: A New Therapeutic Option. Mini-Reviews in Medicinal Chemistry 23:2, pages 159-169.
Crossref
Crossref
Anca Stoica & Dobre Camelia. (2022) Natural strategies of preventing anthracycline-induced cardiotoxicity – a review. Studia Universitatis Babeş-Bolyai Biologia 67:2, pages 5-14.
Crossref
Crossref
Mehmet VADİ & Bahat COMBA. (2022) Resveratrolün Metotreksat Uygulanan Ratlarda Total Oksidan-Antioksidan Durumuna ve DNA Hasarına EtkisiEffect of Resveratrol on Total Oxidative-Antioxidative Status and DNA Damage in Rats Induced Methotrexate. Cumhuriyet Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 7:2, pages 84-91.
Crossref
Crossref
Jingjing Li, Yanfen Cheng, Renkai Li, Xiaoping Wu, Chengwen Zheng, Polly Ho-Ting Shiu, Jacqueline Cho-Ki Chan, Panthakarn Rangsinth, Conghui Liu, Susan Wai-Sum Leung, Simon Ming-Yuen Lee, Chen Zhang, Chaomei Fu, Jinming Zhang, Timothy Man-Yau Cheung & George Pak-Heng Leung. (2022) Protective Effects of Amauroderma rugosum on Doxorubicin-Induced Cardiotoxicity through Suppressing Oxidative Stress, Mitochondrial Dysfunction, Apoptosis, and Activating Akt/mTOR and Nrf2/HO-1 Signaling Pathways. Oxidative Medicine and Cellular Longevity 2022, pages 1-24.
Crossref
Crossref
Jie Wang(a)Yufeng Tang, Jingjing Zhang, Jie Wang(b)Mengjie Xiao, Guangping Lu, Jiahao Li, Qingbo Liu, Yuanfang Guo & Junlian Gu. (2022) Cardiac SIRT1 ameliorates doxorubicin-induced cardiotoxicity by targeting sestrin 2. Redox Biology 52, pages 102310.
Crossref
Crossref
Jacqueline T. Vuong, Ashley F. Stein-Merlob, Richard K. Cheng & Eric H. Yang. (2022) Novel Therapeutics for Anthracycline Induced Cardiotoxicity. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Jessica Maiuolo, Vincenzo Musolino, Micaela Gliozzi, Cristina Carresi, Francesca Oppedisano, Saverio Nucera, Federica Scarano, Miriam Scicchitano, Lorenza Guarnieri, Francesca Bosco, Roberta Macrì, Stefano Ruga, Antonio Cardamone, Anna Rita Coppoletta, Sara Ilari, Annachiara Mollace, Carolina Muscoli, Francesco Cognetti & Vincenzo Mollace. (2022) The Employment of Genera Vaccinium, Citrus, Olea, and Cynara Polyphenols for the Reduction of Selected Anti-Cancer Drug Side Effects. Nutrients 14:8, pages 1574.
Crossref
Crossref
Ahlam M. Alhusaini, Laila M. Fadda, Abeer M. Alanazi, Wedad S. Sarawi, Hatun A. Alomar, Hanaa M. Ali, Iman H. Hasan & Rehab Ahmed Ali. (2022) Nano-Resveratrol: A Promising Candidate for the Treatment of Renal Toxicity Induced by Doxorubicin in Rats Through Modulation of Beclin-1 and mTOR. Frontiers in Pharmacology 13.
Crossref
Crossref
Wei Yu, Chunjuan Chen, Chenxi Xu, De Xie, Qiang Wang, Weidong Liu, Hairong Zhao, Furong He, Bingyang Chen, Yuemei Xi, Yunbo Yan, Linqian Yu & Jidong Cheng. (2022) Activation of p62-NRF2 Axis Protects against Doxorubicin-Induced Ferroptosis in Cardiomyocytes: A Novel Role and Molecular Mechanism of Resveratrol. The American Journal of Chinese Medicine 50:08, pages 2103-2123.
Crossref
Crossref
Pallabi Banerjee & Imteyaz Qamar. 2022. Cardiovascular toxicity and therapeutic modalities targeting cardio-oncology. Cardiovascular toxicity and therapeutic modalities targeting cardio-oncology
195
213
.
Ahlam M. Alhusaini, Abeer M. Alanazi, Laila M. Fadda, Qamraa H. Alqahtani, Wedad S. Sarawi & Iman H. Hasan. (2021) The beneficial efficacy of liposomal resveratrol against doxorubicin-induced hepatotoxicity in rats: Role of TGF-β1 and SIRT1. Journal of King Saud University - Science 33:8, pages 101640.
Crossref
Crossref
Alessandra Quarta, Antonio Gaballo, Biswajita Pradhan, Srimanta Patra, Mrutyunjay Jena & Andrea Ragusa. (2021) Beneficial Oxidative Stress-Related trans-Resveratrol Effects in the Treatment and Prevention of Breast Cancer. Applied Sciences 11:22, pages 11041.
Crossref
Crossref
Ragu Kanagasabai, Krishnamurthy Karthikeyan, Jay L. Zweier & Govindasamy Ilangovan. (2021) Serine mutations in overexpressed Hsp27 abrogate the protection against doxorubicin-induced p53-dependent cardiac apoptosis in mice. American Journal of Physiology-Heart and Circulatory Physiology 321:5, pages H963-H975.
Crossref
Crossref
David S. Monahan, Talal Almas, Robert Wyile, Faisal H. Cheema, Garry P. Duffy & Aamir Hameed. (2021) Towards the use of localised delivery strategies to counteract cancer therapy–induced cardiotoxicities. Drug Delivery and Translational Research 11:5, pages 1924-1942.
Crossref
Crossref
Ozlem Oztopuz, Ozlem Coskun & Basak Buyuk. (2021) Alterations in aquaporin gene expression level on cyclophosphamide-induced cardiac injury and possible protective role of Ganoderma lucidum. Biologia 76:10, pages 3081-3090.
Crossref
Crossref
Li-Feng Hu, Huan-Rong Lan, Xue-Min Li & Ke-Tao Jin. (2021) A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin-Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti-Inflammatory Activities. Oxidative Medicine and Cellular Longevity 2021, pages 1-19.
Crossref
Crossref
David S. Monahan, Eimhear Flaherty, Aamir Hameed & Garry P. Duffy. (2021) Resveratrol significantly improves cell survival in comparison to dexrazoxane and carvedilol in a h9c2 model of doxorubicin induced cardiotoxicity. Biomedicine & Pharmacotherapy 140, pages 111702.
Crossref
Crossref
Kai Hou, Jianliang Shen, Junrong Yan, Chuannan Zhai, Jingxia Zhang, Ji-An Pan, Ye Zhang, Yaping Jiang, Yongbo Wang, Richard Z. Lin, Hongliang Cong, Shenglan Gao & Wei-Xing Zong. (2021) Loss of TRIM21 alleviates cardiotoxicity by suppressing ferroptosis induced by the chemotherapeutic agent doxorubicin. eBioMedicine 69, pages 103456.
Crossref
Crossref
Pushkar Singh Rawat, Aiswarya Jaiswal, Amit Khurana, Jasvinder Singh Bhatti & Umashanker Navik. (2021) Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management. Biomedicine & Pharmacotherapy 139, pages 111708.
Crossref
Crossref
Jude C. Ikewuchi, Catherine C. Ikewuchi, Mercy O. Ifeanacho, Victoria S. Jaja, Esther C. Okezue, Caius N. Jamabo & Kehinde A. Adeku. (2021) Attenuation of doxorubicin-induced cardiotoxicity in Wistar rats by aqueous leaf-extracts of Chromolaena odorata and Tridax procumbens. Journal of Ethnopharmacology 274, pages 114004.
Crossref
Crossref
Pollen K. Yeung, Sheyda Mohammadizadeh, Fatemeh Akhoundi, Kelsey Mann, Remigius U. Agu & Thomas Pulinilkunnil. (2021) Hemodynamic Assessment and In vivo Catabolism of Adenosine 5’-triphosphate in Doxorubicin or Isoproterenol-induced Cardiovascular Toxicity. Drug Metabolism Letters 14:1, pages 80-88.
Crossref
Crossref
Yujie Huang, Ying Xia, Yizhou Tao, Hongmei Jin, Cheng Ji, Stanley Aniagu, Tao Chen & Yan Jiang. (2021) Protective effects of resveratrol against the cardiac developmental toxicity of trichloroethylene in zebrafish embryos. Toxicology 452, pages 152697.
Crossref
Crossref
Panxia Wang, Minghui Wang, Yuehuai Hu, Jianxing Chen, Yanjun Cao, Cui Liu, Zhongkai Wu, Juan Shen, Jing Lu & Peiqing Liu. (2021) Isorhapontigenin protects against doxorubicin-induced cardiotoxicity via increasing YAP1 expression. Acta Pharmaceutica Sinica B 11:3, pages 680-693.
Crossref
Crossref
Bruno M. Moukette, José P. Castelão-Baptista, Luciana Ferreira, Ana M. Silva, Rui F. Simões, Célia Cabral, Constant A. Pieme, Jeanne Y. Ngogang, Vilma A. Sardão & Paulo J. Oliveira. (2021) Afrostyrax lepidophyllus Mildbr. and Monodora myristica (Gaertn.) Dunal Extracts Decrease Doxorubicin Cytotoxicity on H9c2 Cardiomyoblasts. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-12.
Crossref
Crossref
Wen-Pin Huang, Wei-Hsian Yin, Jia-Shiong Chen, Po-Hsun Huang, Jaw-Wen Chen & Shing-Jong Lin. (2021) Fenofibrate attenuates doxorubicin-induced cardiac dysfunction in mice via activating the eNOS/EPC pathway. Scientific Reports 11:1.
Crossref
Crossref
Kendra K. S. Nordgren & Kendall B. Wallace. (2020) Disruption of the Keap1/Nrf2-Antioxidant Response System After Chronic Doxorubicin Exposure In Vivo. Cardiovascular Toxicology 20:6, pages 557-570.
Crossref
Crossref
Alexa N. Carrera, Marianne K.O. Grant & Beshay N. Zordoky. (2020) CYP1B1 as a therapeutic target in cardio-oncology. Clinical Science 134:21, pages 2897-2927.
Crossref
Crossref
José Eduardo Vargas, Renato Puga, Guido Lenz, Cristiano Trindade & Eduardo Filippi-Chiela. (2020) Cellular Mechanisms Triggered by the Cotreatment of Resveratrol and Doxorubicin in Breast Cancer: A Translational In Vitro–In Silico Model. Oxidative Medicine and Cellular Longevity 2020, pages 1-23.
Crossref
Crossref
Mercy O. Ifeanacho, Jude C. Ikewuchi, Catherine C. Ikewuchi, Prince C. Nweke, Ruth Okere & Tukar L.B. Nwate. (2020) Prevention of doxorubicin-induced dyslipidaemia, plasma oxidative stress and electrolytes imbalance in Wistar rats by aqueous leaf-extracts of Chromolaena odorata and Tridax procumbens. Scientific African, pages e00636.
Crossref
Crossref
Irshad Ahmad & Muddasarul Hoda. (2020) Molecular mechanisms of action of resveratrol in modulation of diabetic and non-diabetic cardiomyopathy. Pharmacological Research 161, pages 105112.
Crossref
Crossref
Cun Liu, Xiaoran Ma, Jing Zhuang, Lijuan Liu & Changgang Sun. (2020) Cardiotoxicity of doxorubicin-based cancer treatment: What is the protective cognition that phytochemicals provide us?. Pharmacological Research 160, pages 105062.
Crossref
Crossref
Shynggys Sergazy, Zarina Shulgau, Galina Fedotovskikh, Laura Chulenbayeva, Ayaulym Nurgozhina, Madiyar Nurgaziyev, Elena Krivyh, Yevgeny Kamyshanskiy, Almagul Kushugulova, Alexander Gulyayev & Mohamad Aljofan. (2020) Cardioprotective effect of grape polyphenol extract against doxorubicin induced cardiotoxicity. Scientific Reports 10:1.
Crossref
Crossref
Tayyaba Afsar, Suhail Razak, Ali Almajwal & Dara Al-Disi. (2020) Doxorubicin-induced alterations in kidney functioning, oxidative stress, DNA damage, and renal tissue morphology; Improvement by Acacia hydaspica tannin-rich ethyl acetate fraction. Saudi Journal of Biological Sciences 27:9, pages 2251-2260.
Crossref
Crossref
Fei Ren, Yujie Huang, Yizhou Tao, Cheng Ji, Stanley Aniagu, Yan Jiang & Tao Chen. (2020) Resveratrol protects against PM2.5-induced heart defects in zebrafish embryos as an antioxidant rather than as an AHR antagonist. Toxicology and Applied Pharmacology 398, pages 115029.
Crossref
Crossref
Abeer Alanazi, Laila Fadda, Ahlam Alhusaini & Rehab Ahmad. (2020) Antioxidant, antiapoptotic, and antifibrotic effects of the combination of liposomal resveratrol and carvedilol against doxorubicin‐induced cardiomyopathy in rats. Journal of Biochemical and Molecular Toxicology 34:7.
Crossref
Crossref
Abeer M. Alanazi, Laila Fadda, Ahlam Alhusaini, Rehab Ahmad, Iman H. Hasan & Ayman M. Mahmoud. (2020) Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats. Antioxidants 9:2, pages 159.
Crossref
Crossref
Azar Hosseini, Sahar Sheikh, Mohammad Soukhtanloo, Bizhan Malaekeh-Nikouei & Arezoo Rajabian. (2020)
The effect of hydro-alcoholic extract of
Rheum Turkestanicum
Roots against oxidative stress in endothelial cells
. International Journal of Preventive Medicine 11:1, pages 122.
Crossref
Crossref
Reza Vafaee, Hamid Soori, Mehdi Hedayati, Elaheh Ainy & Hamidreza Hatamabadi. (2019) Effects of resveratrol supplementation in male Wistar rats undergoing an endurance exercise and acute exercise training. Human Antibodies 27:4, pages 257-264.
Crossref
Crossref
Jiamao Lin, Lijun Fang, Hui Li, Zhenxiang Li, Linmao Lyu, Haiyong Wang & Jun Xiao. (2019) Astragaloside IV alleviates doxorubicin induced cardiomyopathy by inhibiting NADPH oxidase derived oxidative stress. European Journal of Pharmacology 859, pages 172490.
Crossref
Crossref
Jing Lu, Jingyan Li, Yuehuai Hu, Zhen Guo, Duanping Sun, Panxia Wang, Kaiteng Guo, Dayue Darrel Duan, Si Gao, Jianmin Jiang, Junjian Wang & Peiqing Liu. (2019) Chrysophanol protects against doxorubicin-induced cardiotoxicity by suppressing cellular PARylation. Acta Pharmaceutica Sinica B 9:4, pages 782-793.
Crossref
Crossref
Trevi R. Mancilla, Brian Iskra & Gregory J. Aune. 2011. Comprehensive Physiology. Comprehensive Physiology
905
931
.
Ahmad Ghorbani, Mohammad Sadegh Amiri & Azar Hosseini. (2019) Pharmacological properties of Rheum turkestanicum Janisch. Heliyon 5:6, pages e01986.
Crossref
Crossref
Ibrahim Abdelgawad, Marianne Grant & Beshay Zordoky. (2019) Leveraging the Cardio-Protective and Anticancer Properties of Resveratrol in Cardio-Oncology. Nutrients 11:3, pages 627.
Crossref
Crossref
Raquel N. Rozner & William H. Frishman. (2019) Cardiovascular Effects of Chemotherapy Used in the Treatment of Breast Cancers. Cardiology in Review 27:2, pages 87-96.
Crossref
Crossref
Xu Cheng, Xiaoli Zeng, Yan Zheng, Xin Wang & Rupei Tang. (2019) Surface-fluorinated and pH-sensitive carboxymethyl chitosan nanoparticles to overcome biological barriers for improved drug delivery in vivo. Carbohydrate Polymers 208, pages 59-69.
Crossref
Crossref
Tao Li, Linlin Chen, Yiyan Yu, Binbin Yang, Pengyun Li & Xiao‑Qiu Tan. (2019) Resveratrol alleviates hypoxia/reoxygenation injury‑induced mitochondrial oxidative stress in cardiomyocytes. Molecular Medicine Reports.
Crossref
Crossref
Yue Gu, Aichun Ju, Bingjie Jiang, Jingze Zhang, Shuli Man, Changxiao Liu & Wenyuan Gao. (2018) Yiqi Fumai lyophilized injection attenuates doxorubicin-induced cardiotoxicity, hepatotoxicity and nephrotoxicity in rats by inhibition of oxidative stress, inflammation and apoptosis. RSC Advances 8:71, pages 40894-40911.
Crossref
Crossref
Nobutoshi Matsumura, Beshay N Zordoky, Ian M Robertson, Shereen M Hamza, Nirmal Parajuli, Carrie-Lynn M Soltys, Donna L Beker, Marianne K Grant, Maria Razzoli, Alessandro Bartolomucci & Jason R B Dyck. (2018) Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes. Cardiovascular Research 114:10, pages 1350-1359.
Crossref
Crossref
Wei Shi, Hongkuan Deng, Jianyong Zhang, Ying Zhang, Xiufang Zhang & Guozhen Cui. (2018) Mitochondria-Targeting Small Molecules Effectively Prevent Cardiotoxicity Induced by Doxorubicin. Molecules 23:6, pages 1486.
Crossref
Crossref
Anthony Cemaluk C Egbuonu & Juliet C Eneogwe. (2018) Phytoalexins: Current and possible future applications in human health and diseases control. International Journal of Molecular Biology 3:3.
Crossref
Crossref
Rajneet Kaur Khurana, Ashay Jain, Atul Jain, Teenu Sharma, Bhupinder Singh & Prashant Kesharwani. (2018) Administration of antioxidants in cancer: debate of the decade. Drug Discovery Today 23:4, pages 763-770.
Crossref
Crossref
Jun Gu, Yu-qi Fan, Hui-li Zhang, Jian-an Pan, Jian-ying Yu, Jun-feng Zhang & Chang-qian Wang. (2018) Resveratrol suppresses doxorubicin-induced cardiotoxicity by disrupting E2F1 mediated autophagy inhibition and apoptosis promotion. Biochemical Pharmacology 150, pages 202-213.
Crossref
Crossref
Katherine E. Washington, Ruvanthi N. Kularatne, Michael C. Biewer & Mihaela C. Stefan. (2018) Combination Loading of Doxorubicin and Resveratrol in Polymeric Micelles for Increased Loading Efficiency and Efficacy. ACS Biomaterials Science & Engineering 4:3, pages 997-1004.
Crossref
Crossref
Takehiro Nakahara, Takashi Tanimoto, Artiom D. Petrov, Kiyotake Ishikawa, H. William Strauss & Jagat Narula. 2018. Experimental Models of Cardiovascular Diseases. Experimental Models of Cardiovascular Diseases
221
232
.
Lanxia Zhao, Xia Zhang, Xin Liu, Juan Li & Yuxia Luan. (2017) pH-responsive poly(ethylene glycol)-poly(ϵ-caprolactone)-poly(glutamic acid) polymersome as an efficient doxorubicin carrier for cancer therapy. Polymer International 66:11, pages 1579-1586.
Crossref
Crossref
Ashay Jain, Gajanand Sharma, Varun Kushwah, Neeraj K Garg, Prashant Kesharwani, Gargi Ghoshal, Bhupinder Singh, Uma Shankar Shivhare, Sanyog Jain & Om Prakash Katare. (2017) Methotrexate and beta-carotene loaded-lipid polymer hybrid nanoparticles: a preclinical study for breast cancer. Nanomedicine 12:15, pages 1851-1872.
Crossref
Crossref
Heba Samy Shoukry, Hania Ibrahim Ammar, Laila Ahmed Rashed, Maha Balegh Zikri, Ashraf Ali Shamaa, Sahar Gamal Abou elfadl, Ejlal Abu-Al Rub, Sekaran Saravanan & Sanjiv Dhingra. (2017) Prophylactic supplementation of resveratrol is more effective than its therapeutic use against doxorubicin induced cardiotoxicity. PLOS ONE 12:7, pages e0181535.
Crossref
Crossref
S. Shabalala, C.J.F. Muller, J. Louw & R. Johnson. (2017) Polyphenols, autophagy and doxorubicin-induced cardiotoxicity. Life Sciences 180, pages 160-170.
Crossref
Crossref
Tao Bai, Xinyue Hu, Yang ZhengShudong Wang, Jian Kong & Lu Cai. (2016) Resveratrol protects against lipopolysaccharide-induced cardiac dysfunction by enhancing SERCA2a activity through promoting the phospholamban oligomerization. American Journal of Physiology-Heart and Circulatory Physiology 311:4, pages H1051-H1062.
Crossref
Crossref
Dona Sinha, Nivedita Sarkar, Jaydip Biswas & Anupam Bishayee. (2016) Resveratrol for breast cancer prevention and therapy: Preclinical evidence and molecular mechanisms. Seminars in Cancer Biology 40-41, pages 209-232.
Crossref
Crossref
Vernon W. Dolinsky, Laura K. Cole, Genevieve C. Sparagna & Grant M. Hatch. (2016) Cardiac mitochondrial energy metabolism in heart failure: Role of cardiolipin and sirtuins. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1861:10, pages 1544-1554.
Crossref
Crossref
Aslı F. CEYLAN & Sinem ASLAN ERDEM. (2016) RESVERATROL, PALMİTAT İLE İNDÜKLENEN ENDOPLAZMİK RETİKULUM STRESİ İNHİBE EDER: ANTİ-APOPTOTİK ETKİ. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi 18:2, pages 68-68.
Crossref
Crossref
Mi‑Hua Liu, Jian Shan, Jian Li, Yuan Zhang & Xiao‑Long Lin. (2016) Resveratrol inhibits doxorubicin‑induced cardiotoxicity via sirtuin�1 activation in H9c2 cardiomyocytes. Experimental and Therapeutic Medicine.
Crossref
Crossref
Alejandro Silva-Palacios, Mina Königsberg & Cecilia Zazueta. (2016) Nrf2 signaling and redox homeostasis in the aging heart: A potential target to prevent cardiovascular diseases?. Ageing Research Reviews 26, pages 81-95.
Crossref
Crossref
Shreesh Ojha, Hasan Al Taee, Sameer Goyal, Umesh B. Mahajan, Chandrgouda R. Patil, D. S. Arya & Mohanraj Rajesh. (2016) Cardioprotective Potentials of Plant-Derived Small Molecules against Doxorubicin Associated Cardiotoxicity. Oxidative Medicine and Cellular Longevity 2016, pages 1-19.
Crossref
Crossref
Mi‑Hua Liu, Xiao‑Long Lin, Dong‑Ming Guo, Yuan Zhang, Cong Yuan, Tian‑Ping Tan, Yu‑Dan Chen, Shao‑Jian Wu, Zu‑Feng Ye & Jun He. (2015) Resveratrol protects cardiomyocytes from doxorubicin‑induced apoptosis through the AMPK/P53 pathway. Molecular Medicine Reports.
Crossref
Crossref
Trinity Vera, Ralph B. D'AgostinoJr.Jr., Jennifer H. Jordan, Matthew C. Whitlock, Giselle C. Mel?ndez, Zanetta S. Lamar, Mercedes Porosnicu, Herbert L. Bonkovsky, Leslie B. Poole & W. Gregory Hundley. (2015) Relation of Pre-anthracycline Serum Bilirubin Levels to Left Ventricular Ejection Fraction After Chemotherapy. The American Journal of Cardiology 116:11, pages 1752-1755.
Crossref
Crossref
Jun Gu, Wei Hu & Da‐dong Zhang. (2015) Resveratrol, a polyphenol phytoalexin, protects against doxorubicin‐induced cardiotoxicity. Journal of Cellular and Molecular Medicine 19:10, pages 2324-2328.
Crossref
Crossref
Brianna Cote, Lisa Janssen Carlson, Deepa A. Rao & Adam W.G. Alani. (2015) Combinatorial resveratrol and quercetin polymeric micelles mitigate doxorubicin induced cardiotoxicity in vitro and in vivo. Journal of Controlled Release 213, pages 128-133.
Crossref
Crossref
BO LI, DO SUNG KIM, RAJ KUMAR YADAV, HYUNG RYONG KIM & HAN JUNG CHAE. (2015) Sulforaphane prevents doxorubicin-induced oxidative stress and cell death in rat H9c2 cells. International Journal of Molecular Medicine 36:1, pages 53-64.
Crossref
Crossref
Luc Rochette, Charles Guenancia, Aurélie Gudjoncik, Olivier Hachet, Marianne Zeller, Yves Cottin & Catherine Vergely. (2015) Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms. Trends in Pharmacological Sciences 36:6, pages 326-348.
Crossref
Crossref
Beshay N.M. Zordoky, Ian M. Robertson & Jason R.B. Dyck. (2015) Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1852:6, pages 1155-1177.
Crossref
Crossref
Qi Dong, Zhiye Wu, Xiaoyun Li, Jianyun Yan, Luning Zhao, Chuntao Yang, Junjiang Lu, Ju Deng & Minsheng Chen. (2014) Resveratrol ameliorates cardiac dysfunction induced by pressure overload in rats via structural protection and modulation of Ca2+ cycling proteins. Journal of Translational Medicine 12:1.
Crossref
Crossref
Vernon Dolinsky & Jason Dyck. (2014) Experimental Studies of the Molecular Pathways Regulated by Exercise and Resveratrol in Heart, Skeletal Muscle and the Vasculature. Molecules 19:9, pages 14919-14947.
Crossref
Crossref
Manar Hamed Arafa, Nanies Sameeh Mohammad, Hebatallah Husseini Atteia & Hesham Radwan Abd-Elaziz. (2014) Protective effect of resveratrol against doxorubicin-induced cardiac toxicity and fibrosis in male experimental rats. Journal of Physiology and Biochemistry 70:3, pages 701-711.
Crossref
Crossref
Nurgul Atmaca, Hasan Tarik Atmaca, Ayse Kanici & Tugce Anteplioglu. (2014) Protective effect of resveratrol on sodium fluoride-induced oxidative stress, hepatotoxicity and neurotoxicity in rats. Food and Chemical Toxicology 70, pages 191-197.
Crossref
Crossref
Sameer Al‑Harthi, Ohoud Alarabi, Wafaa Ramadan, Mohamed Alaama, Huda Al‑Kreathy, Zoheir Damanhouri, Lateef Khan & Abdel‑Moneim Osman. (2014) Amelioration of doxorubicin‑induced cardiotoxicity by resveratrol. Molecular Medicine Reports.
Crossref
Crossref
Lindsay G Carter, John A D'Orazio & Kevin J Pearson. (2014) Resveratrol and cancer: focus on in vivo evidence. Endocrine-Related Cancer 21:3, pages R209-R225.
Crossref
Crossref
Nurgül Atmaca, Ebru Yıldırım, Bayram Güner, Ruhi Kabakçı & Fatih Sultan Bilmen. (2014) Effect of Resveratrol on Hematological and Biochemical Alterations in Rats Exposed to Fluoride. BioMed Research International 2014, pages 1-5.
Crossref
Crossref
Kendra K.S. Nordgren & Kendall B. Wallace. (2014) Keap1 redox-dependent regulation of doxorubicin-induced oxidative stress response in cardiac myoblasts. Toxicology and Applied Pharmacology 274:1, pages 107-116.
Crossref
Crossref
Pema Raj, Xavier Lieben Louis, Sijo Joseph Thandapilly, Ali Movahed, Shelley Zieroth & Thomas Netticadan. (2014) Potential of resveratrol in the treatment of heart failure. Life Sciences 95:2, pages 63-71.
Crossref
Crossref
Yi Xin HuHua CuiLi FanXiu Jie PanJi Hua WuSuo Zhu ShiShao Yuan CuiZhi Min WeiLin Liu. (2013) Resveratrol attenuates left ventricular remodeling in old rats with COPD induced by cigarette smoke exposure and LPS instillation. Canadian Journal of Physiology and Pharmacology 91:12, pages 1044-1054.
Crossref
Crossref
Vernon W. DolinskyKyle J. RoganMiranda M. SungBeshay N. ZordokyMark J. HaykowskyMartin E. Young, Lee W. Jones & Jason R. B. Dyck. (2013) Both aerobic exercise and resveratrol supplementation attenuate doxorubicin-induced cardiac injury in mice. American Journal of Physiology-Endocrinology and Metabolism 305:2, pages E243-E253.
Crossref
Crossref
Nilanjana Ph. D.Vaithinathan Selvaraju, Mandip Joshi, Sainath Kotha, Narasimham Parinandi & Nilanjana Maulik. 2013. Cardiovascular Diseases. Cardiovascular Diseases
401
420
.
Abdel-Moneim M Osman, Sameer E Al-Harthi, Ohoud M AlArabi, Mohamed F Elshal, Wafaa S Ramadan, Mohamed N Alaama, Huda M Al-Kreathy, Zoheir A Damanhouri & Osman H Osman. (2013) Chemosensetizing and cardioprotective effects of resveratrol in doxorubicin- treated animals. Cancer Cell International 13:1, pages 52.
Crossref
Crossref
Shereen M. Hamza, Miranda M. Sung & Jason R. B. Dyck. 2013. Cardiac Remodeling. Cardiac Remodeling
227
254
.
Alexandra König, Christoph Bode & Heiko Bugger. (2012) Diabetes Mellitus and Myocardial Mitochondrial Dysfunction. Heart Failure Clinics 8:4, pages 551-561.
Crossref
Crossref
Miranda M. Y. Sung & Jason R. B. Dyck. (2011) Age-related cardiovascular disease and the beneficial effects of calorie restriction. Heart Failure Reviews 17:4-5, pages 707-719.
Crossref
Crossref
Lonneke Smeding, Howard Leong-Poi, Pingzhao Hu, Yuexin Shan, Jack J. Haitsma, Eva Horvath, Suleiman Furmli, Hussain Masoom, Jan Willem Kuiper, Arthur S. Slutsky, Thomas G. Parker, Frans B. Plötz & Claudia C. dos Santos. (2012) Salutary effect of resveratrol on sepsis-induced myocardial depression*. Critical Care Medicine 40:6, pages 1896-1907.
Crossref
Crossref
Yanti Octavia, Carlo G. Tocchetti, Kathleen L. Gabrielson, Stefan Janssens, Harry J. Crijns & An L. Moens. (2012) Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies. Journal of Molecular and Cellular Cardiology 52:6, pages 1213-1225.
Crossref
Crossref
Thomas Netticadan. (2012)
Why research on resveratrol-mediated cardioprotection should not decelerate
1
This editorial was invited by the Editors.
. Canadian Journal of Physiology and Pharmacology 90:5, pages iii-vi.
Crossref
Crossref
X. Xu, K. Chen, S. Kobayashi, D. Timm & Q. Liang. (2011) Resveratrol Attenuates Doxorubicin-Induced Cardiomyocyte Death via Inhibition of p70 S6 Kinase 1-Mediated Autophagy. Journal of Pharmacology and Experimental Therapeutics 341:1, pages 183-195.
Crossref
Crossref
Abdelkader E. Ashour, Mohamed M. Sayed-Ahmed, Adel R. Abd-Allah, Hesham M. Korashy, Zaid H. Maayah, Hisham Alkhalidi, Mohammed Mubarak & Abdulqader Alhaider. (2012) Metformin Rescues the Myocardium from Doxorubicin-Induced Energy Starvation and Mitochondrial Damage in Rats. Oxidative Medicine and Cellular Longevity 2012, pages 1-13.
Crossref
Crossref
Juan A. Sanchez, Mahesh Thirunavukkarasu & Nilanjana Maulik. 2012. Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome. Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome
413
430
.
Vernon W. Dolinsky & Jason R.B. Dyck. (2011) Calorie restriction and resveratrol in cardiovascular health and disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1812:11, pages 1477-1489.
Crossref
Crossref
V. Ashutosh Rao, Jun Zhang, Sarah R. Klein, Parvaneh Espandiari, Alan Knapton, Jennifer S. Dickey, Eugene Herman & Emily B. Shacter. (2011) The iron chelator Dp44mT inhibits the proliferation of cancer cells but fails to protect from doxorubicin-induced cardiotoxicity in spontaneously hypertensive rats. Cancer Chemotherapy and Pharmacology 68:5, pages 1125-1134.
Crossref
Crossref
Qiong YuanLei ChenDa-Xiong XiangYuan-Jian LiChang-Ping Hu. (2011) Effect of resveratrol derivative BTM-0512 on high glucose-induced dysfunction of endothelial cells: role of SIRT1. Canadian Journal of Physiology and Pharmacology 89:10, pages 713-722.
Crossref
Crossref
L. H. Tadevosyan, L. N. Arakelyan, M. A. Simonyan, G. A. Kevorkian & A. A. Galoyan. (2011) The regulatory influence of galarmin on the level and activity of rat tissue metalloproteins after doxorubicin-induced nephro- and cardiotoxicity. Neurochemical Journal 5:3, pages 215-219.
Crossref
Crossref
Daniel J. Luther, Vahagn Ohanyan, Patricia E. Shamhart, Cheryl M. Hodnichak, Hamayak Sisakian, Tristan D. Booth, J. Gary Meszaros & Anupam Bishayee. (2009) Chemopreventive doses of resveratrol do not produce cardiotoxicity in a rodent model of hepatocellular carcinoma. Investigational New Drugs 29:2, pages 380-391.
Crossref
Crossref
Osama M. Ashour, Ahmed A. Elberry, Abdulrahman Alahdal, Ameen M. Al Mohamadi, Ayman A. Nagy, Ashraf B. Abdel-Naim, Essam A. Abdel-Sattar & Ahmed M. Mohamadin. (2011) Protective effect of bilberry (Vaccinium myrtillus) against doxorubicin-induced oxidative cardiotoxicity in rats. Medical Science Monitor 17:4, pages BR110-BR115.
Crossref
Crossref
Hale Z Toklu, Özer Şehirli, Mehmet Erşahin, Selami Süleymanoğlu, Ömer Yiğiner, Ebru Emekli-Alturfan, Ayşen Yarat, Berrak Ç Yeğen & Göksel Şener. (2010) Resveratrol improves cardiovascular function and reduces oxidative organ damage in the renal, cardiovascular and cerebral tissues of two-kidney, one-clip hypertensive rats. Journal of Pharmacy and Pharmacology 62:12, pages 1784-1793.
Crossref
Crossref
Sergio Granados-Principal, José L. Quiles, Cesar L. Ramirez-Tortosa, Pedro Sanchez-Rovira & MCarmen Ramirez-Tortosa. (2010) New advances in molecular mechanisms and the prevention of adriamycin toxicity by antioxidant nutrients. Food and Chemical Toxicology 48:6, pages 1425-1438.
Crossref
Crossref
Peter Wojciechowski, Danijel Juric, Xavier Lieben Louis, Sijo Joseph Thandapilly, Liping Yu, Carla Taylor & Thomas Netticadan. (2010) Resveratrol Arrests and Regresses the Development of Pressure Overload- but Not Volume Overload-Induced Cardiac Hypertrophy in Rats. The Journal of Nutrition 140:5, pages 962-968.
Crossref
Crossref
Ahmed A. Elberry, Ashraf B. Abdel-Naim, Essam A. Abdel-Sattar, Ayman A. Nagy, Hisham A. Mosli, Ahmed M. Mohamadin & Osama M. Ashour. (2010) Cranberry (Vaccinium macrocarpon) protects against doxorubicin-induced cardiotoxicity in rats. Food and Chemical Toxicology 48:5, pages 1178-1184.
Crossref
Crossref
S. J. Thandapilly, P. Wojciechowski, J. Behbahani, X. L. Louis, L. Yu, D. Juric, M. A. Kopilas, H. D. Anderson & T. Netticadan. (2010) Resveratrol Prevents the Development of Pathological Cardiac Hypertrophy and Contractile Dysfunction in the SHR Without Lowering Blood Pressure. American Journal of Hypertension 23:2, pages 192-196.
Crossref
Crossref
Adriana Albini, Giuseppina Pennesi, Francesco Donatelli, Rosaria Cammarota, Silvio De Flora & Douglas M. Noonan. (2010) Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention. JNCI: Journal of the National Cancer Institute 102:1, pages 14-25.
Crossref
Crossref
Yi-Wei Zhang, Jianjian Shi, Yuan-Jian Li & Lei Wei. (2009) Cardiomyocyte death in doxorubicin-induced cardiotoxicity. Archivum Immunologiae et Therapiae Experimentalis 57:6, pages 435-445.
Crossref
Crossref